CLOVIS ONCOLOGY Forum: Community User: Maroni

Sieht wieder gut aus

geduuuuuld u Ruhe bewahren

Was ist jetzt los?

Hab's geahnt...

Könnte aber nochmal eine kurzfristige Korrektur nach unten geben.. Mal sehen

Kaum schreibt er, geht's wieder abwärts O_o

sieht doch gut aus...ach ja...ich darf nicht mehr schreiben ;))

Das Zick Zack ist wie gestern.. Na dann der Schluss bitte auch wieder so xD

riesiges Potential mMn - vom CHART her,)

Sieht nicht verkehrt aus auf dem ersten Blick

Keep on rollin....

Where Does Wall Street See the Stock Going? Research firms on the Street have price targets on the name ranging from $21 to $50 with a standard deviation of $10.54. The consensus target from the 6 analysts providing projections currently stands at $33.5. The mean target was last revised on 2016-02-29. These are short term projections for the next 12 months.

Nachbörslich nochmal +5 ct Morgen 15:30 Uhr geht's weiter

Ganz interessant die Zusammenfassung: Clovis Oncology Inc (NASDAQ:CLVS) After being trading in a bearish tone since December the stock appears to making a comeback in favor of the bulls. Clovis Oncology Inc (NASDAQ:CLVS) caught my attention today. The signal to buy was given when the previous day high was taken out. This breakout suggests a possible move to $26. The stock showed a lot of strength and I expect to see another round of buying. On the technical side, the chart looks very good here. CLVS call options were also very active today.

Stifel Nicolaus reissued their buy rating on shares ofClovis Oncology Inc (NASDAQ:CLVS) in a report published on Friday, MarketBeat.comreports. They currently have a $30.00 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $45.00.

JPMorgan Chase & Co. reiterated their buy rating on shares of Clovis Oncology Inc (NASDAQ:CLVS)in a research note released on Friday morning,Analyst Ratings.Net reports. The brokerage currently has a $42.00 price objective on the biopharmaceutical company’s stock.